David Adams

Wellcome Trust Sanger Institute Cambridge

David graduated from the University of Technology, Sydney with a BSc (Hons) in Biomedical Science in 1996 having specialised in pathology, haematology and molecular genetics. He worked in clinical diagnostic laboratories before moving to the Department of Physiology at the University of Sydney to undertake a PhD with Professor Brian Morris, which was completed in 2001. David then moved to the Wellcome Trust Sanger Institute in late 2001 to start a postdoc with Professor Allan Bradley. In Allan Bradley's lab David developed an interest in cancer genetics, refined technologies for modifying the mouse genome and developed a large number of mouse models to study disease gene function. 

In 2006 David was awarded a Cancer Research UK Career Development Fellowship and joined the faculty of the Sanger Institute. In 2012 David became a CRUK Senior fellow. David is adjunct-faculty at the Cambridge Cancer Research Institute and works closely with a number of scientists throughout the Cambridge research community. He is a member of Genomel (Genomics of Melanoma Consortium), The Infection, Immunity and Immunophenotyping consortium (3I) and the Deciphering the Mechanisms of Developmental Disorders Consortium (DMDD). He is also on the Steering Committee of the International Mouse Phenotyping consortium and on the scientific advisory board of Phenomin.

Visit lab website